Director of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), Orbimed Advisors Llc, buys 1,285,714 shares worth $4,499,999
According to Corvus Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 04:52 PM, company Director, Orbimed Advisors Llc disclosed buying 1,285,714 shares at a cost of $3.50. At the time of this transaction (Feb 17), this trade was worth $4,499,999 in total. As of Feb 17, Orbimed Advisors Llc now owns 8,053,298 shares in total worth about $30,280,400.479999997.
For the last few recent trades made by Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Director, Orbimed Advisors Llc, we have the following information:
- SEC Form 4 filing: Aug 06: Bought 142,656 shares at the rate of $3.51 per share. Total worth of this trade was $500,723. Total number of shares owned as of Aug 06 were 6,767,584
- SEC Form 4 filing: Jun 27: Bought 32,923 shares at the rate of $3.34 per share. Total worth of this trade was $109,963. Total number of shares owned as of Jun 27 were 6,000,507
- SEC Form 4 filing: Jun 28: Bought 565,178 shares at the rate of $3.72 per share. Total worth of this trade was $2,102,462. Total number of shares owned as of Jun 28 were 6,565,685
Posted by
George Daniels
on Friday February 19 2021, 10:36 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
